|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Fee income | |||||
| Operating expenses | |||||
| Research and development | |||||
| Total expenses | |||||
| Operating loss | |||||
| Net investment income | |||||
| Other income | |||||
| Net loss | |||||
| Basic net loss per common share | |||||
| Diluted net loss per common share | |||||
| Weighted average number of common shares outstanding - Basic | |||||
| Weighted average number of common shares outstanding - Diluted | |||||
Loading...